Experience of an anatomic femoral stem in a UK orthopaedic centre beyond 20 years of follow-up
European Journal of Orthopaedic Surgery & Traumatology · 2024
DOI: 10.1007/s00590-024-03901-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, 2024. Verfasst von G Turnbull und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Treatment Centre Fife Orthopaedics, Victoria Hospital, Hayfield Road, Kirkcaldy, KY2 5AH, Scotland, UK. garethsturnbull@gmail.com. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Periprosthetic Fractures, Reoperation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Increasing interest in the use of anatomical stems has developed as the prevalence of periprosthetic fractures (PPFs) continues to increase. The primary aim of this study was to determine the long-term survivorship and PPF rate of an anatomical femoral stem in a single UK centre. Patients and methods Between 2000 and 2002, 94 consecutive THAs were performed using the 170 mm Lubinus SP II anatomical femoral stem in our institution. Patient demographics, operative details and clinical outcomes were collected prospectively in an arthroplasty database. Patient records and national radiographic archives were reviewed finally at a mean of 21.5 years (SD 0.7) following surgery to identify occurrence of subsequent revision surgery, dislocation or periprosthetic fracture.
Results
Mean patient age at surgery was 65.8 years (SD 12.5, 34–88 years). There were 48 women (51%). Osteoarthritis was the operative indication in 88 patients (94%). Analysis of all-cause THA failure demonstrated a survivorship of 98.5% (95% confidence interval [CI], 98.0–99.3%) at 10 years and 96.7% (94.5–98.9%) at 21 years. The 20-year stem survival for aseptic loosening was 100% with no cases of significant lysis found (lucent line > 2 mm) and no stems required revision. Patient demographics did not appear to influence risk of revision ( p > 0.05). There were 2 revisions in total (2 for acetabular loosening with original stems retained). There were no PPFs identified at mean 21.5 year follow-up and 5 dislocations (5%).
Conclusions
The Lubinus SP II 170 mm stem demonstrated excellent survivorship and negligible PPF rates over 20 years following primary THA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Treatment Centre Fife Orthopaedics, Victoria Hospital, Hayfield Road, Kirkcaldy, KY2 5AH, Scotland, UK. garethsturnbull@gmail.com.
- The Royal Infirmary of Edinburgh, 51 Little France Cres, Old Dalkeith Rd, Edinburgh, EH16 4SA, Scotland, UK. garethsturnbull@gmail.com.
- National Treatment Centre Fife Orthopaedics, Victoria Hospital, Hayfield Road, Kirkcaldy, KY2 5AH, Scotland, UK.
Zitieren
APA
Turnbull, G., Blacklock, C., Akhtar, A., Dunstan, E., & Ballantyne, J. A. (2024). Experience of an anatomic femoral stem in a UK orthopaedic centre beyond 20 years of follow-up. European Journal of Orthopaedic Surgery & Traumatology. https://doi.org/10.1007/s00590-024-03901-1
Vancouver
Turnbull G, Blacklock C, Akhtar A, Dunstan E, Ballantyne JA. Experience of an anatomic femoral stem in a UK orthopaedic centre beyond 20 years of follow-up. European Journal of Orthopaedic Surgery & Traumatology. 2024. doi:10.1007/s00590-024-03901-1
BibTeX
@article{Turnbull2024,
author = {Turnbull, G and Blacklock, C and Akhtar, A and Dunstan, E and Ballantyne, J A},
title = {Experience of an anatomic femoral stem in a UK orthopaedic centre beyond 20 years of follow-up},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2024},
doi = {10.1007/s00590-024-03901-1}
}
EUVIMED